Company Description
Beigene (OTC Link: BEIGF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $29.6B.
BEIGF has gained 37.6% over the past year. Shares last traded at $21.95.
For FY2025, Beigene reported revenue of $5.3B with net income of $286.9M and diluted earnings per share of $0.19. The company operates at a net profit margin of 5.4%.
This page collects what Stock Titan holds for BEIGF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Beigene (BEIGF) stock last closed at $21.95. Over the past 12 months, the stock has gained 37.6%. At a market capitalization of $29.6B, BEIGF is classified as a large-cap stock with approximately 1.4B shares outstanding.
BEIGF Rankings
Latest News
SEC Filings
Beigene has filed 5 recent SEC filings, including 4 Form 4, 1 Form 144. The most recent filing was submitted on July 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BEIGF SEC filings →
Financial Highlights
Beigene generated $5.3B in revenue in FY2025, retaining a 87.5% gross margin, operating income reached $447.1M (8.4% operating margin), and net income was $286.9M, reflecting a 5.4% net profit margin. Diluted earnings per share stood at $0.19. The company generated $1.1B in operating cash flow. With a current ratio of 3.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Beigene (BEIGF) currently stands at 165.5 thousand shares, up 151.4% from the previous reporting period, representing 0.0% of the float. Since July 2025, short interest has decreased by 35.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Beigene (BEIGF) currently stands at 4.2 days, up 233.9% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 27.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BEIGF Company Profile & Sector Positioning
Beigene (BEIGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.